Muscle wasting in chronic kidney disease (CKD) is a common yet underrecognized complication, tightly intertwined with ...

Trutakna (atacicept-vymj), a first-in-class dual BAFF and APRIL inhibitor, secured FDA accelerated approval to reduce proteinuria in adults with primary IgA nephropathy, supported by data ...

Study findings support the use of Stockholm3 for risk-adapted prostate cancer screening. The net benefit for detecting clinically significant prostate cancer (csPC) is greater with Stockholm3 vs PSA, ...

Anti-drug antibody positivity often paralleled B-cell reconstitution and did not uniformly predict rituximab failure.

Surgeons who socialize for 2 or more hours past their usual bedtime on their days off are more likely to incur major surgical adverse events. Sleep regularity more so than sleep d ...

Risk scores increased over time among women who developed cancer, while women who were cancer-free had stable scores. (HealthDay News) — Artificial intelligence-based risk scores from screening ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders, according to a research letter published online June 24 in JAM ...

Plasma cell-targeted therapy has emerged as a potential adjunctive therapy for recurrent focal segmental glomerulosclerosis (FSGS) following kidney transplantation, according to a case series ...

In trial participants with mild to moderate CKD and recent atrial fibrillation, antiarrhythmic drugs did not increase the risk for heart failure hospitalization, death, or stroke compared with heart ...

Greater clinical net benefit for Stockholm3, driven by fewer false-negative results. (HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic ...

Each additional hour per day of prolonged sedentary behavior is associated with a higher hazard of cancer death.